Half, how is the last PR an advancement of the technology? We have known for years that Recaf detects prostate, breast, and ovarian cancer. We have known for years that a Recaf test combined with other markers could at least reduce false positives. What is new news about this PR?
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.